Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (851-860 of 993) with videos related to

Pageof 100
Sort By:
Clinical Genitourinary Cancer|November 19, 2023
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma PatientsLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Minerva Urology and Nephrology|August 2, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registriesAndrea Panunzio, Stefano Tappero, Mattia Piccinelli, et al.
The Lancet. Oncology|June 16, 2025
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trialNeeraj Agarwal, Arun A Azad, Joan Carles, et al.
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2021
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trialKarim Fizazi, Pablo González Mella, Daniel Castellano, et al.
BMC Urology|September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationVéronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
International Journal of Cancer|December 31, 2024
Life expectancy in rare histological prostate cancer subtypesCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Critical Care Medicine|January 8, 2025
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney CancerCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2024
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortalityCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Clinical Genitourinary Cancer|February 18, 2024
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all StagesCarolin Siech, Simone Morra, Lukas Scheipner, et al.
Pageof 100

Showing results (851-860 of 993) with videos related to

Sort By:
Pageof 100
Clinical Genitourinary Cancer|November 19, 2023
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma PatientsLukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
Minerva Urology and Nephrology|August 2, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registriesAndrea Panunzio, Stefano Tappero, Mattia Piccinelli, et al.
The Lancet. Oncology|June 16, 2025
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trialNeeraj Agarwal, Arun A Azad, Joan Carles, et al.
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2021
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trialKarim Fizazi, Pablo González Mella, Daniel Castellano, et al.
BMC Urology|September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationVéronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
International Journal of Cancer|December 31, 2024
Life expectancy in rare histological prostate cancer subtypesCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Critical Care Medicine|January 8, 2025
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney CancerCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2024
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortalityCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Clinical Genitourinary Cancer|February 18, 2024
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all StagesCarolin Siech, Simone Morra, Lukas Scheipner, et al.
Pageof 100